SEC Form 4 · accession 0001499807-17-000006

K2M GROUP HOLDINGS, INC. · KTWO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Medical Officer · Director

Period of report

Jan 20, 2017

Accepted (ET)

Jan 24, 2017 · 4:43 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001499807

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 20, 2017	M	10,006	$9.26	A	259,113	D
Common Stock	Jan 20, 2017	M	17,284	$15.00	A	276,397	D
Common Stock	Jan 20, 2017	M	675	$23.46	A	277,072	D
Common Stock^F2	Jan 20, 2017	S	27,965	$21.61	D	249,107	D
Common Stock	Jan 23, 2017	M	561	$23.46	A	249,668	D
Common Stock	Jan 23, 2017	S	561	$21.7922	D	249,107	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$9.26	Jan 20, 2017	M	10,006	D	—	Feb 26, 2021	Common Stock	10,006	0	D
Stock Option (Right to Buy)^F3	$15.00	Jan 20, 2017	M	17,284	D	—	May 7, 2024	Common Stock	17,284	0	D
Stock Option (Right to Buy)^F4	$23.46	Jan 20, 2017	M	675	D	—	Jul 1, 2025	Common Stock	675	13,125	D
Stock Option (Right to Buy)^F4	$23.46	Jan 23, 2017	M	561	D	—	Jul 1, 2025	Common Stock	561	12,564	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2The price in Column 4 is a weighted average. The prices actually received ranged from $21.21 to $21.78. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3An option which is fully vested.
F4An option which vests in three equal installments on July 1, 2016, July 1, 2017 and July 1, 2018.